Bigul

Proceedings Of National Company Law Tribunal Convened Separate Meetings Of The Equity Shareholders And Unsecured Creditors Of Sun Pharmaceutical Industries Limited Held On June 20, 2017

Pursuant to the order dated April 18, 2017, passed by the Hon'ble National Company Law Tribunal, Ahmedabad Bench, the separate meetings of equity shareholders and unsecured creditors of the Company were held at Sir Sayajirao Nagargruh, Akota, Vadodara- 390 020, Gujarat on Tuesday, June 20, 2017 at 10.15 a.m. and 11: 15 a.m. respectively, for approving the Scheme of Arrangement among Sun Pharma Medisales Private Limited, Ranbaxy Drugs Limited, Gufic...
20-06-2017
Bigul

Fund managers make contrarian bets on pharma stocks

Sun Pharma emerged as top choice since equity mutual funds added about 15 mn shares to portfolio
20-06-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pratham Investments
19-06-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Sudhir Valia
15-06-2017
Bigul

Pharma stocks rise; Sun Pharma top gainer

In the Nifty50 pack, 21 stocks were trading in green, while 30 stocks were in red.
15-06-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Vrundavandas Valia & Raksha Sudhir Valia
14-06-2017
Bigul

Sun Pharma's niche drug ramp-up key to growth

Despite the Zetia launch, FY18 could be subdued given pricing pressures
14-06-2017
Bigul

Updates

Dear Sirs, Sub:Press Release We are pleased to enclose herewith our Press Release relating to US FDA approval of generic Zetia (ezetimibe) Tablets 10mg in US, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you,
13-06-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Vrundavandas Valia & Raksha Sudhir Valia
08-06-2017
Bigul

Sun Pharma wants to rise on niche route

Lost 50% market value in 2 years due to competition
08-06-2017
Next Page
Close

Let's Open Free Demat Account